Governmental Non-Pharmaceutical Interventions during the COVID-19 Pandemic and the COPD Exacerbation and Respiratory Infection Rate in Patients with Alpha-1 Antitrypsin Deficiency

Impact of Coronavirus Disease 2019 Related Infection Prevention and Control Measures on the Occurrence of COPD Exacerbations During Inpatient Pulmonary Rehabilitation

(2023) Kiki Waeijen-Smit et al.   Chronic Obstructive Pulmonary Diseases-Journal of the COPD Foundation

A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker)

(2021) Thomas Hale et al.   Nature Human Behaviour

Impact of COVID-19 lockdown on the incidence and mortality of acute exacerbations of chronic obstructive pulmonary disease: national interrupted time series analyses for Scotland and Wales

(2021) Mohammad A. Alsallakh et al.   BMC Medicine

Population Decline in COPD Admissions During the COVID-19 Pandemic Associated with Lower Burden of Community Respiratory Viral Infections

(2021) Jennifer Y. So et al.   AMERICAN JOURNAL OF MEDICINE

Reduction in hospitalised COPD exacerbations during COVID-19: A systematic review and meta-analysis

(2021) Jaber S. Alqahtani et al.   PLoS One

Prevalence of Alpha-1 Antitrypsin Deficiency, Self-Reported Behavior Change, and Health Care Engagement Among Direct-to-Consumer Recipients of a Personalized Genetic Risk Report

(2021) James R. Ashenhurst et al.   CHEST

Acceptability of hygiene, face covering and social distancing interventions to prevent exacerbations in people living with airways diseases

(2021) John R Hurst et al.   THORAX

Alpha1-Antitrypsin Deficiency

(2020) Pavel Strnad et al.   NEW ENGLAND JOURNAL OF MEDICINE

Seasonality of Respiratory Viral Infections

(2020) Miyu Moriyama et al.   Annual Review of Virology

COVID-19 public health measures: a reduction in hospital admissions for COPD exacerbations

(2020) Jing Yuan Tan et al.   THORAX

COVID-19 and ‘basal’ exacerbation frequency in COPD

(2020) Daryl O Cheng et al.   THORAX

Efficacy and safety of inhaled alpha-1-antitrypsin in patients with severe alpha-1-antitrypsin deficiency and frequent exacerbations of Chronic Obstructive Pulmonary Disease

(2019) Jan Stolk et al.   EUROPEAN RESPIRATORY JOURNAL

Treatment with inhaled α1-antitrypsin: a square peg in a round hole?

(2019) Miriam Barrecheguren et al.   EUROPEAN RESPIRATORY JOURNAL

A time for everything and everything in its time – exploring the mechanisms underlying seasonality of COPD exacerbations

(2018) Alexander Hicks et al.   International Journal of Chronic Obstructive Pulmonary Disease